clinicalomicsprowebdirectory
Facebook
Linkedin
Twitter
News
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Virtual Event
Learning Labs
Podcasts
Inside Precision Medicine Live
Search
Facebook
Linkedin
Twitter
Update Preferences
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Inside Precision Medicine
News
News & Features
Seattle Hub for Synthetic Biology Launched with Jay Shendure at the…
News & Features
3D Printing Could Build Tissues within Body
News & Features
Class of Diabetes Drugs May Prevent Development of Colorectal Cancer
News & Features
Map of DDX3X Gene Shows Impacts to the Health of Any…
News & Features
Smear Test Flags Ovarian Cancer
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Virtual Event
Learning Labs
Podcasts
Inside Precision Medicine Live
Rhythm Pharmaceuticals
Informatics
Genomenon, Rhythm Pharma Partner on Database of Obesity Mutations
Clinical OMICs Staff Writer
-
April 24, 2018
0
Related Content
In Big Obesity Move, Roche Acquires Carmot Therapeutics for $2.7B Up Front
Personalis Lands Tempus as Partner to Co-Commercialize Its MRD Test in Lung and Breast Cancer
Smartwatch Data Plus Digital Twin Framework Predicts Risk of Heart Disease and Heart Attack
Breast Cancer Cells Use Basement Membrane Barrier to Become Invasive
Inside Precision Medicine
![Genomenon said today it has partnered with Rhythm Pharmaceuticals to create a database of genetic mutations associated with obesity as documented in published studies. Rhythm plans to use the data to better understand rare genetic disorders of obesity. [Visual Mozart/Getty Images]](https://www.insideprecisionmedicine.com/wp-content/uploads/2019/01/1628-768x794.jpeg "Genomenon, Rhythm Pharma Partner on Database of Obesity Mutations")
